The modulation of in viva hippocampal ACh release by dopaminergic Dl and D2 receptors was examined in this study. Additionally, in an attempt to ascertain the location of these receptors in relation to hippocampal cholinergic terminals, fimbriaectomy and quantitative autoradiography were used. Following unilateral fimbriaectomy, whereby at least 50% of hippocampal cholineacetyltransferase (ChAT) activity was lost, a significant ipsilateral decrease in DlPH SCH23390 binding was observed in the molecular layer of the dentate gyrus while hippocampal D2PH raclopride binding was unaffected.
The effects of prototypical Dl and D2 receptor agonists and antagonists on hippocampal ACh release were examined next using in wivo dialysis in freely moving rats. The Dl agonist SKF 38393 (10 @VI to 100 PM) administered directly into the hippocampus via the dialysis probe stimulated ACh release in a concentration dependent manner. The effect of the agonist was blocked by the coadministration of the Dl receptor antagonist SCH 23390 (1 PM), which by itself failed to modulate ACh release. In contrast, neither the D2 agonist quinpirole nor the D2 antagonist sulpiride (l-10 (LM) had any direct effect on hippocampal ACh release. Additionally, the infusion of these Dl and D2 drugs in the septal area failed to affect hippocampal ACh release. Taken together, these results suggest that a proportion of hippocampal Dl receptors are located on cholinergic nerve terminals and that dopamine, acting via Dl receptors, can locally stimulate hippocampal ACh release.
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Dl receptor] Dopamine (DA) is thought to modulate the activity of the septohippocampal cholinergic pathway (Robinson et al., 1979; Costa et al., 1983) . Infusions of dopamine antagonists into the septum increase the firing rate of this pathway (Robinson et al., 1979) and elevate ACh turnover (Robinson et al., 1979) and high affinity choline uptake (Durkin et al., 1986) in the hippocampus.
Similar effects are also observed following either intraseptal 6-hydroxydopamine injection (Robinson et al., 1979) or the destruction of the ventral tegmental A10 dopaminergic neurons (Robinson et al., 1979; Galey et al., 1985) . It has been suggested that A10 dopaminergic neurons projecting to the lateral septum interact with chohnergic fibers originating from the medial septal nucleus, possibly via septal GABAergic interneurons, to bring about this inhibitory influence (Wood, 1985) . On the other hand, a variety of wide ranging studies including morphological (Scatton et al., 1980; Verney et al., 1985; Simon et al., 1989) electrophysiological (Gribkoff et al., 1984; Stanzione et al., 1984; Smialowski et al., 1987) and biochemical (Bischoff, 1979; Ishikawa, 1982) approaches provide evidence suggesting that the hippocampus receives direct dopaminergic innervation. This innervation apparently originates mainly from the ventral tegmental area (VTA; and to a lesser extent from the substantia nigra) and ascends in the medial forebrain bundle to innervate various hmbic structures, including the hippocampus (Verney et al., 1985) . Dopamine receptors have been classified in two broad families (Dl-like and D2-like) on the basis of the activity of various agonists and antagonists (Kebabian and Came, 1979; Seeman, 1980) . More recently, molecular cloning techniques have shown that the Dl family comprises two receptors (dl and d5) while the D2 family consists of at least three different receptor proteins (d2, d3, and d4) (for a recent review, see Niznik and Van Tol, 1992) . Dl receptors activate adenylate cyclase whereas members of the D2 receptor class have been shown to couple to numerous effector systems, including the inhibition of adenylate cyclase and the activation of potassium channels, among others (Monsma et al., 1990; Sibley and Monsma, 1992) . Both the Dl and the D2 receptor subtypes have been localized in the septum as well as the hippocampus of various mammalian species including the rat (Bischoff et al., 1980; Bruink et al., 1986; Dawson et al., 1986; Grilh et al., 1988; Tiberi et al., 1991; Mengod et al., 1992) .
Given this background, it is thus likely that dopamine may act as a modulator of the septo-hippocampal cholinergic pathway both at the level of the cell bodies in the septal area and at the nerve terminals within the hippocampus.
In the present study, these two possibilities were investigated directly by examining the effects of local administration of selective dopamine Dl and D2 receptor agonists and antagonists on hippocampal ACh release using in vivo dialysis in freely moving rats as well as by evaluating the effects of unilateral fimbriaectomy on these receptors in the hippocampus as monitored by quantitative autoradiography.
Our Homogenates from these punches were incubated for 15 min in a buffer containing '-'C acetyl CoA as previously described m detail (Araujo et al., 1988) using the method of Fonnum (1969) as modified by Tucek (1978) . The animals that were used in subsequent receptor autoradiographic studies showed hippocampal ChAT activity losses of 5 I -t 4% on the lesioned side as compared to the contralateral hippocampi. Doprrrtiinr rewpfor crlrtor~~t/iogrup12?'. The status of hippocampal dopaminergic receptors following fimbriaectomy was assessed as described in detail elsewhere (Debonnel et al., 1990) . In brief, following sectioning at -17°C. 20 pm hippocampal slices were incubated for 60 min at room temperature in SO mM Tris HCL buffer (pH 7.4) containing I20 mM NCI. 5 -ITIM KCI, 2 mM CaCI,.
I mM Mgdl,, and I .O nM 'H SCH 23390 for Dl receotors or 5.7 nM 'H raclooride for D2 receptors. Serial sections were in&bated in this buffer but-with the addition of I FM SCH 23390 or I pM (+) butaclamol to ascertain the specificity of the DI or D2 radioligand binding, respectively. The sections were then rinsed five times (2 min each) in fresh ice-cold buffer. Buffer salts were removed by a rapid dip in ice-cold distilled water and the sections rapidly air dried. Autoradiograms were generated by apposing the sections alongside with tritium standards to tritium sensitive films for 4 weeks. The films were then developed as described before (Quirion et al., 1981) Transverse probes (Damsma et al., 19X7) were stereotaxically implanted in the dorsal hippocampus and for septally manipulated animals also in the lateral septum (Giovannini et al.. 1994 ) at coordinates of 3.8 mm posterior to bregma and 3.5 mm below the skull f~)r the hippocampus and 0.7 mm anterior to bregma and 4.5 111111 below the skull for the septum (Paxinos and Watson. 1982) . The animals were individually housed and allowed to recover from surgery for 2 d prior to their use in the irl viva dialysis experiments.
Each animal was dialyzed only once.
At the beginning of each dialysis experiment. animals were placed in lidless cages and connected to a BAS microliter syringe pump in a manner as to allow them to freely move in the cages. The probes were perfused for a one hour wash out period at a fow rate of 2. binding was observed in the molecular layer of the dentate gyrus of the ipsilateral hippocampus in lesioned animals (29.9 -+ 0.8 vs 36.6 2 I.1 fmol/mg tissue wet weight) (Fig. 1A.B) . No detectable differences were observed in 'H SCH 23390 binding in CA], CA2, and CA3 subfields between the ipsi-and contralateral hippocampi of fimbriaectomized rats (Fig. IA.@ . 'H SCH 23390 binding levels were similar in the hippocampus of sham operated animals as compared to the contralateral hippocampi of the fimbriaectomized animals (data not shown). Hippocampal D2PH raclopride binding was considerably lower than that of DIPH SCH 23390. Using JH raclopride, the only detectable amount of specific binding in the dorsal hippocampus was observed in the CA1 and subicular regions (Fig. IC) . No differences were seen between ipsi-and contra-lateral hippocampi of unilaterally fimbriaectomized animals (Fig. ID) . Additionally, no detectable changes of either ?H SCH 23390 or 'H raclopride binding levels were observed in the septum or cortical regions as a result of unilateral fimbriaectomy. In all the animals used here, ChAT activity in the ipsilateral hippocampi decreased by 51 2 4% as compared to the contralateral hippocampi or the hippocampus of sham operated animals.
Local dopuminergic receptor modulation qf hippocampal ACh release The average basal efflux of ACh from the dorsal hippocampus was 4.8 pmol/25 min (n = 52). Moreover, there were no appreciable differences in basal ACh release between the various experimental groups studied here. Hippocampal intraprobe administration of the active enantiomer of the selective DI agonist (+)SKF 38393 (IO-100 PM), but not the inactive enantiomer (-)SKF 38393 (10 PM), increased ACh release in a concentration dependent manner ( Fig. 2A) . The Dl antagonist SCH 23390 (l-10 (IM), by itself, had no appreciable effect on hippocampal ACh release in freely behaving animals (Fig. 2B) . However, the coinfusion of the Dl antagonist (1 FM) with the Dl agonist (10 FM) blocked the stimulatory effect of the latter (Fig. 2C) . Under the conditions used here, neither the D2 agonist quinpirole HCI (I-IO FM) (Fig. 3A) nor the D2 antagonists sulpiride (l-10 FM) (Fig. 3B) or eticlopride (IO p,M, data not shown) significantly modified hippocampal ACh release. Interestingly, when infused in to the lateral septum neither the Dl nor D2 drugs had an effect on hippocampal ACh release (Fig. 4) . No appreciable obvious behavioral sequeleae (locomotion, sniffing, grooming, etc.) were induced by these dopaminergic drugs administered via the probe. D#"sion qf hippocumpally infused .?H SCH23390 3H SCH 23390 (1 PM, I PCi) infused via the probe for 4 hr showed virtually no diffusion beyond the hippocampal area immediately in contact with the dialysis probe (Fig. 5) . Considering that this concentration of the unlabelled Dl antagonist blocked the stimulation of hippocampal ACh release induced by the Dl agonist SKF 38393, it suggests that this effect is occurring locally.
Discussion
A variety of studies have demonstrated the presence of direct dopaminergic innervation into the hippocampus. This innervation is concentrated in the ventral subiculum, in particular in the presubiculum (Vemey et al., 1985) . Hippocampal Dl receptors, on the other hand, are mainly located in the molecular layer of the dentate gyrus and the dorsal hippocampus (Dawson et al., 1986; Grilli et al., 1988; Tiberi et al., 1991) . In the present study, we observed that a significant portion of Dl receptors in the molecular layer of the dentate gyrus was lost following fimbriaectomy. This suggests that a proportion of hippocampal Dl receptors are located presynaptically on afferent terminals. Moreover, a concomitant reduction in hippocampal ChAT activity was observed as a result of the lesion. Considering that a , 1985) . it is logical to assume that at least some of the lost Dl receptors are located on cholinergic nerve terminals.
Interestingly, i n seni l e dementia of the Alzheimer's type (SDAT), a marked reduction in hippocampal Dl receptors has been reported (Cartes et al., 1988) , with the highest loss (89%) seen i n the molecular layer of the dentate gyrus. It is well known that one of the hallmarks of SDAT is the destruction of basal forebrain cholinergic neurons which, in part, project to the hippocampus (Davies and Maloney, 1976; Whitehouse et al., 1982; Coyle et al., 1983) . Therefore, in agreement with these studies, the re- duction in hippocampal Dl receptors observed here could be due to the loss of presynaptically located receptors resulting from the cholinergic denervation. Nevertheless, the possibility that some of these Dl receptors are located on afferents other than cholinergic that are contained within the fimbria-fornix projection cannot be excluded solely on the basis of the present experiments.
D2 receptors, on the other hand, are found in the hippocampus 1 mCi/mmol) was perfused for 4 hr in the dorsal hippocampus as described in Materials and -Methods; 20 p,rn brain sections from these animals were exposed to tritium sensitive films and photomicrographs taken. A shows the extent of diffusion of the radioactive material; B, a schematic representation of the section in A. The arrows mark the location of the dialysis probe. It is rather evident that diffusion was minimal and the infused radioactivity remained in close proximity to the dialysis probe. Abbreviations: CA, Ammon's horn; DC, dentate ~vrus; HY, in very low amounts compared to Dl receptor levels (Fig. 1D) . In the dorsal hippocampus, D2i3H raclopride binding sites are mainly located in the CA1 and subiculum regions (Fig. 1C) . In the present study, no alteration in hippocampal D2 receptor densities were observed following fimbriaectomy. It would thus appear that this dopamine receptor subtype is not directly associated with the septo-hippocampal cholinergic nerve projection.
drugs into the dorsal hippocampus had any effect on ACh release.
Recently, the technique of in vivo dialysis has been used to study the possible regulation by dopaminergic drugs of the septo-hippocampal cholinergic pathway. Systemic administration of dopaminergic drugs has shown that dopamine potentially stimulates hippocampal ACh release via both Dl and D2 receptor subtypes (Imperato et al., 1993) or the Dl subtype alone (Day and Fibiger, 1994) in young animals, and at least via Dl receptors in aged-memory impaired rats (Hersi et al., 1994) . A number of possible loci exist for this apparent interaction between DA and ACh. Given the direct dopaminergic innervation of the hippocampus and the putative localization of Dl receptors on hippocampal terminals (see above), a direct modulation of hippocampal ACh release by DA drugs is a likely possibility.
Another possible locus for AC!h/DA interaction is the lateral septal area. Dopaminergic projections arising from the VTA and terminating in the lateral septum were postulated to interact with the cholinergic cell bodies of the medial septum that give rise to the cholinergic septo-hippocampal pathhway (Wood, 1985) . In the present study, the manipulation of neither Dl nor D2 receptors in the septal area had any effect on hippocampal ACh release. Thus, it would appear that dopamine stimulates hippocampal ACh release by acting on Dl receptors located in the hippocampus. However, although the lesion data presented here suggests that these Dl receptors are located on cholinergic terminals, the possibility of transsynaptic action involving interneurons or other noncholinergic afferents cannot be ruled out at the present time.
The Dl receptor agonist (+)SKF 38393 applied directly into the hippocampus via the dialysis probe stimulated, in a concentration dependent, ACh release. This effect was blocked by the Dl antagonist SCH 23390 while the inactive stereoisomer (-)SKF 38393 had no effect by itself, attesting to the specificity of the effect for the Dl receptor family. SCH 23390 infused alone in the dialysis probe did notialter hippocampal ACh levels. These findings suggest that the Dl receptors located in the dorsal hippocampus can enhance ACh release and that this action is likely phasic in nature, in view of the lack of effect of the Dl antagonist alone.
A question arises, however, as to the extent of diffusion of locally applied drugs in the in vivo dialysis paradigm used here. This is especially pertinent considering the relatively long period of drug infusion. Administration of 3H SCH 23390 under conditions identical to those used for the nonradioactive drugs, showed that diffusion is rather minimal and that the ligand is mostly, if not exclusively, found in the area surrounding the dialysis probe (Fig. 5) . Thus, it would appear that local interaction can account for the effects of Dl drugs on hippocampal ACh release as observed in the present study or following systemic administration (Imperato et al., 1993; Day and Fibiger, 1994; Hersi et al., 1994) .
In the classical view of the synapse, a close juxtaposition must exist between the nerve fiber terminals .enriched with a given neurotransmitter and its postsynaptic receptors. However, this is clearly not always the case and may even be the exception (Beaudet and Descarries, 1978) . Discrepancies between the localization of receptors and the distribution of the relevant neurotransmitter has been referred to as the mismatch issue (Kuhar, 1985; Herkenham, 1987) . In the present situation, the hippocampal dopaminergic innervation, arising mainly from the VTA and the substantia nigra, is mostly restricted to the ventral hippocampus (Verney et al., 1985) . In contrast, hippocampal dopaminergic receptors are predominantly found in the dorsal hippocampus (Dawson et al., 1986; Grilli et al., 1988; Tiberi et al., 1991; this study) . Interestingly, however, more than 40% of the dopamine present in the hippocampus has been proposed to be located within dorsal noradrenergic terminals (Bischoff et al., 1979) . It may be conceivable that, under certain conditions, dopamine and noradrenaline may be coreleased from the terminals of the latter present in the dorsal hippocampus. It is also tempting to suggest that crossover between neurotransmitters may exist to partly account for the apparent mismatches. For instance, under excessive cell firing conditions, the release of noradrenaline in quantities large enough to saturate its own receptors may lead to the binding of this neurotransmitter to other related receptor families such as those for dopamine. In this way, a secondary level of complexity would be added to code for signal strength and more effective transmission. In contrast to Dl drugs, neither the stimulation nor the blockAnother intriguing possibility to account for apparent ligandade of D2 receptors by local, intraprobe infusion of prototypical receptor mismatches is known as volume transmission (VT). In hypothalamus; TH, thalamus:
contrast to the classical synaptic mode of signal transmission, VT refers to the diffusion of chemical signals in the extracellular fluid. A neurotransmitter could thus act at a considerable distance from its site of release (for a recent review, see Benfenati and Agnati, 1991) . For example, it has been reported that when transient parkinsonism is induced in cats following MPTP administration, dopamine released from spared ventral striatum terminals can diffuse over a distance of 5.5-7.0 mm to the more extensively denervated dorsolateral striatum (Schneider et al., 1994) . Similarly, dopamine released from fiber terminals located in the ventral hippocampus could diffuse to the dorsal part where the dopaminergic Dl receptors are mostly found. However, direct evidence in support of this possibility have yet to be provided. Interestingly, Dl receptors have, in the past, been linked with volume transmission in areas such as the median eminence and globus pallidus (Fuxe et al., 1988) . In any case, it is evident from the data reported here that the activation of DI receptors present in the dorsal hippocampus can modulate ACh release and are hence fully functional.
Finally, it should be added that the physiological significance of the dopaminergic system in the hippocampus is not yet clear. lntrahippocampal injections of dopamine receptor agonists evoke theta rhythms in hippocampal electroencephalograms (Smialowski, 1985) . This type of rhythmic oscillation is known to occur during periods of learning (Winson, 1978) . Moreover, during theta oscillation, hippocampal synapses are in a state of heightened plasticity and the stimulatory requirements for the induction of long term potentiation (LTP) are markedly reduced (Huerta and Lisman, 1993) . Interestingly, a well established role of the hippocampal cholinergic nerve terminals is to elicit theta rhythms (Bland, 1986) . Most recently, dopamine was reported to modify LTP in the Schaffer collateral pathway of the rat hippocampus via DI receptors (Huang and Kandel, 1995) . In addition, mnemonic deficits in aged rats can be attenuated by Dl receptor agonists, and this effect was proposed to be mediated by the release of ACh in the hippocampus (Hersi et al., 1994) . Therefore, it appears that a role for DA in the hippocampus could, at least in part, be associated with learning and memory, likely via the modulation of hippocampal cholinergic functions. In summary, a certain proportion of hippocampal Dl receptors appears to be located directly on septo-hippocampal cholinergic nerve terminals. Moreover, in viva hippocampal ACh release is facilitated by the local stimulation of Dl but not D2 receptors. Recent data have clearly shown that the Dl receptor family comprises both the dl and d5 subtypes (see introductory section). At present, it is unclear which of these two subtypes is involved in the modulation of hippocampal ACh release as selective probes have yet to be developed to discriminate between these members of the DI receptor family. Other strategies such as the use of functional receptor antibodies or oligonucleotide antisenses would have to be used.
